Mammotome: Less Invasive than ABBI with Similar Accuracy for Early Breast Cancer Detection

Weber, Walter; Zanetti, Rosanna; Langer, Igor; Dellas, Sophie; Moch, H.; Remmel, Eugenia; Oertli, Daniel; Wight, Edward; Marti, Walter R.

doi:10.1007/s00268-004-7635-6

Cited by 15 publications

(17 citation statements)

References 52 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While the ABBI procedure tends to be less invasive than the traditional open surgical biopsy, this technique has not gained widespread acceptance. It uses a probe with a rotating circular knife and thin heated electrical wire to remove a large cylinder of abnormal tissue 47 . In some centres, the biopsy is guided by an MRI, which locates the tumours, plots its co-ordinates, and aims the stereotactic biopsy device into the tumour.…”

Section: The Abbi Methods (Abbi Also Known As Large Core Biopsy Is a Bmentioning

confidence: 99%

The Role of Various Modalities in Breast Imaging

Prasad¹,

Houserková²

2007

BIOMED PAP

View full text Add to dashboard Cite

Background: Breast cancer is the most common type of cancer in women worldwide. Mammography is considered the "gold standard" in the evaluation of the breast from an imaging perspective. Apart from mammography, ultrasound examination and magnetic resonance imaging are being off ered as adjuncts to the preoperative workup. Recently, other new modalities like positron emission tomography, 99mTc-sestamibi scintimammography, and electrical impedance tomography (EIT) are also being off ered. However, there is still controversy over the most appropriate use of these new modalities. Based on the literature, this review evaluates the role of various modalities used in the screening and diagnosis of breast cancer.Methods and Results: Based on relevant literatures this article gives an overview of the old and new modalities used in the fi eld of breast imaging. A narrative literature review of all the relevant papers known to the authors was conducted. The search of literatures was done using pubmed and ovid search engines. Additional references were found through bibliography reviews of relevant articles. It was clear that though various new technics and methods have emerged, none have substituted mammography and it is still the only proven screening method for the breast as of date.Conclusion: From the literature it is clear that apropos modern radiology's impact on diagnosis, staging and patient follow-up, only one imaging technique has had a signifi cant impact on screening asymptomatic individuals for cancer i.e.; low-dose mammography. Mammography is the only screening test proven in breast imaging. Positron emission tomography (PET) also plays an important role in staging breast cancer and monitoring treatment response. As imaging techniques improve, the role of imaging will continue to evolve with the goal remaining a decrease in breast cancer morbidity and mortality. Progress in the development and commercialisation of EIT breast imaging system will defi nitely help to promote other systems and applications based on the EIT and similar visualization methods. Breast ultrasound and breast magnetic resonance imaging (MRI) are frequently used adjuncts to mammography in today's clinical practice and these techniques enhance the radiologist's ability to detect cancer and assess disease extent, which is crucial in treatment planning and staging.

show abstract

Section: The Abbi Methods (Abbi Also Known As Large Core Biopsy Is a Bmentioning

confidence: 99%

The Role of Various Modalities in Breast Imaging

Prasad¹,

Houserková²

2007

BIOMED PAP

View full text Add to dashboard Cite

show abstract

“…• the pooled data suggested that vacuum-assisted breast biopsy with ultrasonography or X-ray mammography could be promising for diagnosis and treatment of breast disease • the results from the 36 articles with 20 868 cases showed high technical success and low complication risks including haematoma, bleeding, skin ecchymosis, pain, vasovagal reflex, and infection • the combination of VABB with US or mammography could be a promising candidate of the standard biopsy methods for detecting nonpalpable lesions controlled trial (RCT) (74 cases), 40 and 4 non-randomised controlled trials (NRCTs) (574 cases), [41][42][43][44] describing a total of 20 868 patients (mean age, 36-56 years), derived from China (7), United States (6), Italy (5), Germany (5), Korea (2), Japan (2), Spain (1), Poland (1), France (1), United Arab…”

Section: Key Messagesmentioning

confidence: 99%

Feasibility and safety of image‐guided vacuum‐assisted breast biopsy: A PRISMA‐compliant systematic review and meta‐analysis of 20 000 population from 36 longitudinal studies

Fang

Liu

Luo

et al. 2019

International Wound Journal

View full text Add to dashboard Cite

Breast cancer is a serious disease in women. We estimated the global technical success rate and complication rates of percutaneous vacuum‐assisted breast biopsy (VABB). PubMed, Embase, Web of Science, and Scopus databases were retrieved up to July 2018 to find studies in which technical success rate and complication rates of VABB were available. Pooled rates were calculated according to location mode (ultrasonography [US] or mammography) and needle type (8‐ or 11‐gauge Mammotome probes). Of the 36 articles with 20 868 cases, we found the pooled technical success rate 0.9999(0.9997, 1.0000) (I2 = 17.1%, P = .187) and low complication risks including haematoma 0.1092(0.0748, 0.1437) (I2 = 98.3%, P < .001), pain 0.0738(0.0334, 0.1141) (I2 = 95.9%, P < .001), vasovagal reflex 0.0281(0.0035, 0.0527) (I2 = 92.5%, P < .001), and infection 0.0027(−0.0019, 0.0073) (I2 = 49.8%, P = .113). In this systematic review and meta‐analysis, the pooled data suggested that VABB with US or mammography could be promising for diagnosis and treatment of breast disease. Further studies were necessary to identify strategies for these findings.

show abstract

“…Particularly, it is unique for nonpalpable breast lesions and mammography‐detected microcalcifications (2–6). Second, compared with the classic biopsy core, MMT probe could obtain much larger volume sample, resulting in high accuracy and specificity in pathologic diagnosis (1–11). Finally, the MMT procedure is accomplished by single minimal invasion, resulting in minimal risk of needle tract seeding of breast cancer (12).…”

mentioning

confidence: 99%

“…Finally, the MMT procedure is accomplished by single minimal invasion, resulting in minimal risk of needle tract seeding of breast cancer (12). Accordingly, MMT system other than any of automated core needle, the advanced breast biopsy instrument system, fine needle aspiration biopsy and diagnostic surgery, is still the best for breast biopsy (7,9,10,13–15).…”

mentioning

confidence: 99%

Therapeutic Application of Ultrasound-Guided 8-Gauge Mammotome System in Presumed Benign Breast Lesions

Luo¹,

Chen²,

Tang³

et al. 2011

The Breast Journal

View full text Add to dashboard Cite

The stereotactic or ultrasound-guided vacuum-assisted breast biopsy (Mammotome, MMT) system is a minimally invasive surgical technique. Increasingly, it is used to remove benign breast lesions as management. To evaluate the therapeutic value of 8-gauge ultrasound-guided MMT system (UMS) in presumed benign breast lesions, a retrospective analysis was performed on a series of 2,167 consecutive 8-gauge UMS procedures. The parameters used in this analysis included lesion size, location, breast imaging reporting and data system for ultrasound category, histopathologic diagnosis, and others. A total of 1,119 women whose mean ages were 36.6 years (range: 12-71, SD: 9.6) underwent 2,167 consecutive 8-gauge UMS procedures. Among the patients, 298 cases (26.63%) did not have palpable mass, 430 (38.43%) had multiple lesions, and 237 (21.18%) had bilateral ones. The average size of excised lesions was 15.8 mm (range: 5-55, SD: 6.7) in the largest dimension, including 294 lesions < 10 mm (13.57%); 1,359 lesions, 10-19 mm (62.71%); 420 lesions, 20-29 mm (19.38%), and 94 lesions ≥ 30 mm (4.34%). Predominant lesions (81.59%) were solid on ultrasound image and nearly half (48.59%) of them were localized in the upper outer quadrant. Histopathologic diagnosis revealed that the overwhelming majority of specimens (96.61%) were benign, most of which manifested as fibroadenoma and fibrocystic changes, while high-risk lesions were revealed in 31 (2.29%) cases and malignancies in 15 (1.11%). Average time for procedure was 8.6 minutes (range: 3.5-38, SD: 5.4) and mean number of cores removed in the procedure was 9.3 (range: 2-42, SD: 3.7). Complete excision was achieved predominantly (99.82%). Complications (59, 5.27%) in which hematoma (41, 3.66%) was the majority were acceptable. In conclusion, the 8-gauge UMS procedure is a safe and potent therapeutic management with satisfactory cosmetic outcome for benign and high-risk breast lesions, especially for bilateral, multiple, and nonpalpable ones. It is a reliable biopsy tool for suspected lesions as well. Eradication and maximal cosmesis can be achieved with few complications if the targeted lesion is limited to 30 mm.

show abstract

Mammotome: Less Invasive than ABBI with Similar Accuracy for Early Breast Cancer Detection

Cited by 15 publications

References 52 publications

The Role of Various Modalities in Breast Imaging

The Role of Various Modalities in Breast Imaging

Feasibility and safety of image‐guided vacuum‐assisted breast biopsy: A PRISMA‐compliant systematic review and meta‐analysis of 20 000 population from 36 longitudinal studies

Therapeutic Application of Ultrasound-Guided 8-Gauge Mammotome System in Presumed Benign Breast Lesions

Contact Info

Product

Resources

About